Ross Maltz

9PUBLICATIONS
9CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)Social epidemiologyPanel data analysisInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 01, 2026
Induction-phase infliximab monitoring accelerates time to remission in pediatric IBD: a retrospective cohort study.

|Jul 31, 2026
Infliximab originator and biosimilars have similar efficacy in children with inflammatory bowel disease.

|Jul 28, 2026
Esophageal Eosinophilia in Pediatric and Young Adult Patients with Inflammatory Bowel Disease: Diagnosis, Clinical Course, and Treatment Outcomes.

|May 05, 2026
Evaluating prescribing trends and medication access of adalimumab biosimilars in pediatric and adolescent care.

|Jan 12, 2026
Young Adults with Inflammatory Bowel Disease in the US Experience Gaps in Healthcare Access and Financial Stress: Additional Findings from a Recent Survey by the Crohn's & Colitis Foundation.

Ross M Maltz, Ariel A Jordan, Shubha Bhat

|Jul 21, 2025
Predictors of antitumor necrosis factor primary nonresponse and drug durability in pediatric inflammatory bowel disease.

Nicole Davidson, Grant A Morris, Molly A Wright

Pageof 2

Frequent Collaborators

1 joint publications

Nicole Davidson

1 joint publications

Mary Harkins-Schwarz

1 joint publications

Orna G Ehrlich

1 joint publications

Hilary K Michel